FDA Approves Genio 2.1 For Use in DREAM U.S. IDE Pivotal Study
New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude [...] Read more »
FDA Approves Genio 2.1 For Use in DREAM U.S. IDE Pivotal Study
New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude [...] Read more »
NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced that ICONIQ Investment Management [...] Read more »
FARMINGDALE, N.Y., June 01, 2022 (GLOBE NEWSWIRE) — D'Addario, the world's premier guitar string maker, is proud to announce the inaugural celebration of #WorldStringChangeDay on Monday, June 6, 2022.
As the [...] Read more »
Stockholm, Sweden, June 01, 2022 (GLOBE NEWSWIRE) — Stratipath, a global leader in AI–based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath [...] Read more »